Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Function and accuracy of glucose sensors beyond their stated expiry date

R Chlup, D Jelenova, K Chlupova, J Zapletalova, L Chlupova, J Bartek

. 2006 ; 8 (4) : 495-504.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13030851

Grantová podpora
NR7825 MZ0 CEP - Centrální evidence projektů

BACKGROUND: The sensor of the Continuous Glucose Monitoring System (CGMS, Medtronic Minimed, Northridge, CA) is labeled to expire 6 months following its production and to measure the glucose concentration in interstitial fluid up to 3 days after insertion. The purpose of this study was to demonstrate potential possibilities of sensors when used beyond their expiry date. METHODS: Twenty sensors, each between 3 to 18 months after the expiry date, were assessed in a 7-day period after insertion. Twenty healthy volunteers 23.4 +/- 2.92 (mean +/- SD) years old were trained in handling the CGMS and the Hypoguard (Woodbridge, UK) Advance glucometer system to measure their capillary plasma glucose concentration 18 times a day. Sensor function was estimated according to the number of readings per day, the accuracy according to the mean absolute difference (MAD), and correlation coefficient (r) between glucometer and sensor resulting from paired values. RESULTS: Uninterrupted sensor function was found in 117 of 140 sensor-days (83.6%). A reduction of readings in 23 sensor-days (16.4%) was caused by user error (5 sensor-days, 3.6%), connecting cable (7 sensor-days, 5%), sensor failure (8 sensor-days, 5.7%), or uncertain factors (3 sensor-days, 2.1%). MAD was always < 28%, and r = 0.79. CONCLUSIONS: Neither the expiry date nor the 3-day period of use limits the reliable function of a CGMS sensor. Sensors were found to function as long as 18 months after the expiry date, mostly for at least 7 days. There were no serious local adverse reactions. Prolongation of shelflife label and insertion time appears to be reasonable. Further studies are in progress.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc13030851
003      
CZ-PrNML
005      
20200228143945.0
007      
ta
008      
130926s2006 xxuad f 000 0|eng||
009      
AR
024    7_
$a 10.1089/dia.2006.8.495 $2 doi
035    __
$a (PubMed)16939374
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chlup, Rudolf, $d 1947- $7 jn20001031001 $u Institute of Physiology and IInd Department of Medicine, Faculty of Medicine, Palacký University, Olomouc, Czech Republic
245    10
$a Function and accuracy of glucose sensors beyond their stated expiry date / $c R Chlup, D Jelenova, K Chlupova, J Zapletalova, L Chlupova, J Bartek
504    __
$a Literatura
520    9_
$a BACKGROUND: The sensor of the Continuous Glucose Monitoring System (CGMS, Medtronic Minimed, Northridge, CA) is labeled to expire 6 months following its production and to measure the glucose concentration in interstitial fluid up to 3 days after insertion. The purpose of this study was to demonstrate potential possibilities of sensors when used beyond their expiry date. METHODS: Twenty sensors, each between 3 to 18 months after the expiry date, were assessed in a 7-day period after insertion. Twenty healthy volunteers 23.4 +/- 2.92 (mean +/- SD) years old were trained in handling the CGMS and the Hypoguard (Woodbridge, UK) Advance glucometer system to measure their capillary plasma glucose concentration 18 times a day. Sensor function was estimated according to the number of readings per day, the accuracy according to the mean absolute difference (MAD), and correlation coefficient (r) between glucometer and sensor resulting from paired values. RESULTS: Uninterrupted sensor function was found in 117 of 140 sensor-days (83.6%). A reduction of readings in 23 sensor-days (16.4%) was caused by user error (5 sensor-days, 3.6%), connecting cable (7 sensor-days, 5%), sensor failure (8 sensor-days, 5.7%), or uncertain factors (3 sensor-days, 2.1%). MAD was always < 28%, and r = 0.79. CONCLUSIONS: Neither the expiry date nor the 3-day period of use limits the reliable function of a CGMS sensor. Sensors were found to function as long as 18 months after the expiry date, mostly for at least 7 days. There were no serious local adverse reactions. Prolongation of shelflife label and insertion time appears to be reasonable. Further studies are in progress.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    12
$a selfmonitoring glykemie $x přístrojové vybavení $7 D015190
650    12
$a extracelulární tekutina $x chemie $7 D045604
650    02
$a ženské pohlaví $7 D005260
650    12
$a glukosa $x analýza $7 D005947
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a časové faktory $7 D013997
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zmeškalová, Daniela $7 xx0211319 $u Institute of Pathophysiology, Faculty of Medicine, Palacký University, Olomouc, Czech Republic
700    1_
$a Chlupová, Karolína $7 _AN035017 $u Institute of Physiology, Faculty of Medicine, Palacký University, Olomouc, Czech Republic; Institute of Diabetes Gerhardt Katsch, Karlsburg, Germany
700    1_
$a Zapletalová, Jana $7 xx0111614 $u Institute of Biophysics, Faculty of Medicine, Palacký University, Olomouc, Czech Republic
700    1_
$a Chlupová, Ludmila $7 _AN035019 $u Department of Special Education, Pedagogical Faculty, Palacký University, Olomouc, Czech Republic
700    1_
$a Bartek, Josef, $d 1951- $7 nlk20000083871 $u Institute of Mecical Chemistry and Biochemistry, Faculty of Medicine, Palacký University, Olomouc, Czech Republic
773    0_
$t Diabetes Technology & Therapeutics $x 1520-9156 $g Roč. 8, č. 4 (2006), s. 495-504 $p Diabetes Technol Ther $w MED00173679
773    0_
$p Diabetes Technol Ther $g 8(4):495-504, 2006 Aug $x 1520-9156
910    __
$a ABA008 $y 3 $z 0
990    __
$a 20130926141858 $b ABA008
991    __
$a 20200228144356 $b ABA008
999    __
$a ok $b bmc $g 994966 $s 829295
BAS    __
$a 3
BMC    __
$a 2006 $b 8 $c 4 $d 495-504 $i 1520-9156 $m Diabetes technology & therapeutics $x MED00173679 $n Diabetes Technol Ther
GRA    __
$a NR7825 $p MZ0
LZP    __
$a 2013-09/dpbo
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace